Exelixis
EXEL
#1561
Rank
A$17.56 B
Marketcap
$62.53
Share price
0.96%
Change (1 day)
81.02%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company